Prestige Consumer Healthcare Retained Earnings (Accumulated Deficit) 2010-2024 | PBH
Prestige Consumer Healthcare retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Prestige Consumer Healthcare Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $1,341 |
| 2023 | $1,132 |
| 2022 | $1,214 |
| 2021 | $1,009 |
| 2020 | $844 |
| 2019 | $702 |
| 2018 | $736 |
| 2017 | $397 |
| 2016 | $327 |
| 2015 | $227 |
| 2014 | $149 |
| 2013 | $76 |
| 2012 | $11 |
| 2011 | $-26 |
| 2010 | $-55 |
| 2009 | $-88 |
| Prestige Consumer Healthcare Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,506 |
| 2024-09-30 | $1,445 |
| 2024-06-30 | $1,390 |
| 2024-03-31 | $1,341 |
| 2023-12-31 | $1,292 |
| 2023-09-30 | $1,239 |
| 2023-06-30 | $1,185 |
| 2023-03-31 | $1,132 |
| 2022-12-31 | $1,372 |
| 2022-09-30 | $1,320 |
| 2022-06-30 | $1,269 |
| 2022-03-31 | $1,214 |
| 2021-12-31 | $1,162 |
| 2021-09-30 | $1,112 |
| 2021-06-30 | $1,067 |
| 2021-03-31 | $1,009 |
| 2020-12-31 | $973 |
| 2020-09-30 | $932 |
| 2020-06-30 | $888 |
| 2020-03-31 | $844 |
| 2019-12-31 | $807 |
| 2019-09-30 | $769 |
| 2019-06-30 | $736 |
| 2019-03-31 | $702 |
| 2018-12-31 | $841 |
| 2018-09-30 | $803 |
| 2018-06-30 | $772 |
| 2018-03-31 | $736 |
| 2017-12-31 | $776 |
| 2017-09-30 | $461 |
| 2017-06-30 | $430 |
| 2017-03-31 | $397 |
| 2016-12-31 | $386 |
| 2016-09-30 | $354 |
| 2016-06-30 | $322 |
| 2016-03-31 | $327 |
| 2015-12-31 | $313 |
| 2015-09-30 | $285 |
| 2015-06-30 | $254 |
| 2015-03-31 | $227 |
| 2014-12-31 | $204 |
| 2014-09-30 | $182 |
| 2014-06-30 | $166 |
| 2014-03-31 | $149 |
| 2013-12-31 | $133 |
| 2013-09-30 | $130 |
| 2013-06-30 | $97 |
| 2013-03-31 | $76 |
| 2012-12-31 | $57 |
| 2012-09-30 | $45 |
| 2012-06-30 | $25 |
| 2012-03-31 | $11 |
| 2011-12-31 | $11 |
| 2011-09-30 | $2 |
| 2011-06-30 | $-11 |
| 2011-03-31 | $-26 |
| 2010-12-31 | $-33 |
| 2010-09-30 | $-35 |
| 2010-06-30 | $-46 |
| 2010-03-31 | $-55 |
| 2009-12-31 | $-59 |
| 2009-09-30 | $-69 |
| 2009-06-30 | $-79 |
| 2009-03-31 | $-88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.059B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.329B | 27.30 |
| Boston Scientific (BSX) | United States | $151.960B | 38.05 |
| Stryker (SYK) | United States | $141.576B | 30.43 |
| EssilorLuxottica (ESLOY) | France | $131.433B | 0.00 |
| Medtronic (MDT) | Ireland | $108.503B | 15.84 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.360B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.382B | 26.36 |
| ResMed (RMD) | United States | $34.859B | 26.18 |
| GE HealthCare Technologies (GEHC) | United States | $31.175B | 15.16 |
| Agilent Technologies (A) | United States | $30.637B | 20.24 |
| Terumo (TRUMY) | Japan | $28.678B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.336B | 12.85 |
| Insulet (PODD) | United States | $17.646B | 75.46 |
| Baxter (BAX) | United States | $15.890B | 11.43 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.790B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.119B | 17.50 |
| Bio-Rad Laboratories (BIO) | United States | $6.788B | 23.50 |
| Perrigo (PRGO) | Ireland | $3.496B | 10.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 28.78 |
| Haemonetics (HAE) | United States | $3.214B | 15.12 |
| Envista Holdings (NVST) | United States | $2.745B | 22.19 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 15.23 |
| LeMaitre Vascular (LMAT) | United States | $2.092B | 47.73 |
| QuidelOrtho (QDEL) | United States | $1.928B | 16.15 |
| AtriCure (ATRC) | United States | $1.715B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.258B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.250B | 19.63 |
| BioLife Solutions (BLFS) | United States | $1.174B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.129B | 10.87 |
| Neogen (NEOG) | United States | $1.092B | 13.97 |
| InMode (INMD) | Israel | $1.003B | 9.18 |
| Phibro Animal Health (PAHC) | United States | $0.765B | 11.73 |
| Evolus (EOLS) | United States | $0.746B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.596B | 0.00 |
| CeriBell (CBLL) | United States | $0.587B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.574B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.61 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.493B | 0.00 |
| Surmodics (SRDX) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.419B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.346B | 15.02 |
| Verano Holdings (VRNOF) | United States | $0.307B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 24.82 |
| ZimVie (ZIMV) | United States | $0.264B | 15.78 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.237B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 4.43 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.89 |
| Brainsway (BWAY) | Israel | $0.168B | 52.29 |
| Organigram Global (OGI) | Canada | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.99 |
| Jin Medical (ZJYL) | China | $0.140B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.121B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.86 |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 0.00 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.11 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |